Art

J-GLOBAL ID：201702275115034363   Reference number：17A0654100

Successful use of propranolol for congenital hepatic hemangioma with Kasabach-Merritt phenomenon

Kasabach-Merritt現象のある先天性肝血管腫に対するプロプラノロールの成功した使用

Author (5)： Kawahara Yuta (Department of Pediatrics, Jichi Medical University School of Medicine, Shimotsuke, Japan) ,  Nijima Hitomi (Department of Pediatrics, Jichi Medical University School of Medicine, Shimotsuke, Japan) ,  Suzuki Yume (Department of Pediatrics, Jichi Medical University School of Medicine, Shimotsuke, Japan) ,  Furukawa Rieko (Department of Pediatric Medical Imaging, Jichi Medical University School of Medicine, Shimotsuke, Japan) ,  Morimoto Akira (Department of Pediatrics, Jichi Medical University School of Medicine, Shimotsuke, Japan)
Material： Pediatrics International (Web)  (Pediatr Int (Web))
Volume： 59  Issue： 5  Page： 634-636  Publication year： 2017 
JST Material Number： U0706A  ISSN： 1442-200X  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： *hemangioma ,...
Semi thesaurus term： *Kasabach-Merritt Syndrome ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0654100&from=J-GLOBAL&jstjournalNo=U0706A") }}

Author keywords (5)： congenital hemangioma ,  corticosteroid ,  hepatic hemangioma ,  Kasabach-Merritt phenomenon ,  propranolol

JST classification (5)： Clinical oncology in general  (GE03010Y) ,  Tumors(=neoplasms)of digestive system  (GH04000D) ,  Tumors(=neoplasms)of cardiovascular system  (GJ04000J) ,  Clinical hematology in general  (GK01030Y) ,  Treatment for pediatric diseases.  (GC08040I)

Substance index (3)： Propranolol ,  Gabexate mesylate ,  Methylprednisolone

Reference (5)：

• Hsi Dickie B, Fishman SJ, Azizkhan RG. Hepatic vascular tumors. Semin. Pediatr. Surg. 2014; 23: 168-72.
• Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N. Engl. J. Med. 2008; 358: 2649-51.
• Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br. J. Dermatol. 2010; 163: 269-74.
• Chiu YE, Drolet BA, Blei F et al. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Pediatr. Blood Cancer 2012; 59: 934-8.
• Su L, Wang D, Fan X. Comprehensive therapy for hemangioma presenting with Kasabach-Merritt syndrome in the maxillofacial region. J. Oral Maxillofac. Surg. 2015; 73: 92-8.

Terms in the title (4)： 現象 ,  肝血管腫 ,  プロプラノロール ,  成功